Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant chemotherapy after curative treatment of oligometastatic colorectal cancer
ChiCTR2000036454Phase 3Not yet recruiting
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in colorectal cancer (CRC) comparing Adjuvant chemotherapy with Observation and follow-up (2 arms). Primary endpoint: 3-year disease-free survival. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
adjuvant chemotherapy
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2000036454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036454.